Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators.

Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17.


Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.

Li W, O'Shaughnessy J, Hayes D, Campone M, Bondarenko I, Zbarskaya I, Brain E, Stenina M, Ivanova O, Graas MP, Neven P, Ricci D, Griffin T, Kheoh T, Yu M, Gormley M, Martin J, Schaffer M, Zelinsky K, De Porre P, Johnston SR.

Clin Cancer Res. 2016 Dec 15;22(24):6002-6009. Epub 2016 Jun 7.


Dietetic and Psychological Mindfulness Workshops for the Management of Cachectic Cancer Patients. A Randomized Study.

Focan C, Houbiers G, Gilles L, Van Steeland T, Georges N, Maniglia A, Lobelle JP, Baro V, Graas MP.

Anticancer Res. 2015 Nov;35(11):6311-5.


[pericarditis following 5-fluorouracil administration].

Maréchal S, Racaru V, Houbiers G, Graas MP.

Rev Med Liege. 2015 Jul-Aug;70(7-8):360-6. French.


Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma.

De Grève J, Moran T, Graas MP, Galdermans D, Vuylsteke P, Canon JL, Schallier D, Decoster L, Teugels E, Massey D, Chand VK, Vansteenkiste J.

Lung Cancer. 2015 Apr;88(1):63-9. doi: 10.1016/j.lungcan.2015.01.013. Epub 2015 Jan 23.


The downward spiral of mental disorders and educational attainment: a systematic review on early school leaving.

Esch P, Bocquet V, Pull C, Couffignal S, Lehnert T, Graas M, Fond-Harmant L, Ansseau M.

BMC Psychiatry. 2014 Aug 27;14:237. doi: 10.1186/s12888-014-0237-4. Review.


[Cancer recurrence or sarcoidosis: the essential contribution of pathology].

Davin A, Graas MP, Demolin G, Namur G, Massart B, Focan C.

Rev Med Liege. 2014 Mar;69(3):155-61. French.


Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.

Baselga J, Gómez P, Greil R, Braga S, Climent MA, Wardley AM, Kaufman B, Stemmer SM, Pêgo A, Chan A, Goeminne JC, Graas MP, Kennedy MJ, Ciruelos Gil EM, Schneeweiss A, Zubel A, Groos J, Melezínková H, Awada A.

J Clin Oncol. 2013 Jul 10;31(20):2586-92. doi: 10.1200/JCO.2012.46.2408. Epub 2013 Jun 3.


[A trans-hospital pilot programme for onco-geriatry. The experience of the CHC-Liege].

Focan C, Warzee E, Demolin G, Houbiers G, Kreutz F, Matus G, Longree L, Sondag C, Dammel F, Guillaume T, Graas MP.

Rev Med Liege. 2013 Mar;68(3):110-7. French.


[Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?].

Graas MP, Houbiers G, Demolin G, Stultiens A, Focan C.

Rev Med Liege. 2012 Dec;67(12):644-8. French.


[Chronotherapy with 5-fluorouracil folinic acid and oxaliplatin delivered over 48 hours every second week in colorectal cancer. The CHC-Liège experience (Belgium)].

Focan C, Demolin G, Kreutz F, Graas MP, Longrée L, Matus G, Moeneclaey N, Focan-Henrard D.

Pathol Biol (Paris). 2013 Oct;61(5):e71-4. doi: 10.1016/j.patbio.2011.02.002. Epub 2012 Oct 22. French.


Psychosocial risk and protective factors of secondary school dropout in Luxembourg: the protocol of an exploratory case-control study.

Esch P, Bocquet V, Pull C, Couffignal S, Graas M, Lair ML, Lehnert T, Fond-Harmant L, Ansseau M.

BMC Public Health. 2011 Jul 13;11:555. doi: 10.1186/1471-2458-11-555.


[Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers].

Focan C, Kreutz F, Longrée L, Graas MP, Moeneclaey N, Demolin G, Focan-Henrard D.

Pathol Biol (Paris). 2007 Apr-May;55(3-4):181-5. Epub 2007 Apr 5. French.


[Adjuvant chemotherapy for Dukes B2 and C colon cancer combining 5-fluorouracil and folinic acid with or without carboplatin. Feasibility and comparison between standard and chronomodulated deliveries].

Focan C, Bury J, Matus G, Graas MP, Kreutz F, Longree L, Moeneclaey N, David A, Focan-Henrard D.

Pathol Biol (Paris). 2005 Jun;53(5):281-4. Epub 2005 Jan 28. French.


[Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer].

Focan C, Kreutz F, Graas MP, Longrée L, Moeneclaey N, David A, Focan-Henrard D.

Pathol Biol (Paris). 2005 Jun;53(5):277-80. Epub 2005 Jan 28. French.


[Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study].

Focan C, Kreutz F, Longrée L, Graas MP, Focan-Henrard D, Moeneclaey N, David A, Biquet JF, Materne R, Weerts J, Delforge M.

Pathol Biol (Paris). 2005 Jun;53(5):273-6. Epub 2005 Jan 28. French.


Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trial.

Focan C, Graas MP, Beauduin M, Canon JL, Salmon JP, Jerusalem G, Focan-Henrard D, Lobelle JP, Schallier D.

Anticancer Res. 2005 Mar-Apr;25(2B):1211-7.


The sentinel lymph node biopsy in breast cancer.

Weerts JM, Maweja S, Tamigneaux I, Dallemagne B, Jourdan JL, Markiewicz S, Monami B, Wahlen Ch, Lastra M, Hénon V, Gomez P, Lilet H, Dwelshauwers J, Graas MP, Focan Ch, Lipczei B, Abraham F, Jehaes C.

Acta Chir Belg. 2002 Apr;102(2):110-3.


[Clinical case of the month. Metastatic endocarditis: clinical observation and review of the literature].

Graas MP, Evrard P, Creemers E, Longrée L, Limet R, Focan C.

Rev Med Liege. 1998 Oct;53(10):588-91. Review. French.


[Clozapine in the treatment of mental manifestations of Parkinson disease].

Diederich N, Keipes M, Graas M, Metz H.

Rev Neurol (Paris). 1995 Apr;151(4):251-7. Review. French.


Supplemental Content

Support Center